These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10775848)

  • 41. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
    Ogino A; Yoshino A; Katayama Y; Watanabe T; Ota T; Komine C; Yokoyama T; Fukushima T
    J Neuropathol Exp Neurol; 2005 May; 64(5):398-403. PubMed ID: 15892297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How disruption of cell cycle regulating genes might predispose to sun-induced skin cancer.
    Rünger TM; Vergilis I; Sarkar P; DePinho RA; Sharpless NE
    Cell Cycle; 2005 May; 4(5):643-5. PubMed ID: 15846097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Normal repair of ultraviolet radiation-induced DNA damage in familial melanoma without CDKN2A or CDK4 gene mutation.
    Shannon JA; Matias C; Luxford C; Kefford RF; Mann GJ
    Melanoma Res; 1999 Apr; 9(2):133-7. PubMed ID: 10380935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequent genetic defects in the p16/INK4A tumor suppressor in canine cell models of breast cancer and melanoma.
    Lutful Kabir FM; DeInnocentes P; Bird AC; Bird RC
    In Vitro Cell Dev Biol Anim; 2021 May; 57(5):519-530. PubMed ID: 34014456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors.
    Haferkamp S; Scurr LL; Becker TM; Frausto M; Kefford RF; Rizos H
    J Invest Dermatol; 2009 Aug; 129(8):1983-91. PubMed ID: 19212341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding.
    Becker TM; Rizos H; Kefford RF; Mann GJ
    Clin Cancer Res; 2001 Oct; 7(10):3282-8. PubMed ID: 11595726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultraviolet B light induces G1 arrest in human melanocytes by prolonged inhibition of retinoblastoma protein phosphorylation associated with long-term expression of the p21Waf-1/SDI-1/Cip-1 protein.
    Medrano EE; Im S; Yang F; Abdel-Malek ZA
    Cancer Res; 1995 Sep; 55(18):4047-52. PubMed ID: 7664278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. UVB-irradiated keratinocytes induce melanoma-associated ganglioside GD3 synthase gene in melanocytes via secretion of tumor necrosis factor α and interleukin 6.
    Miyata M; Ichihara M; Tajima O; Sobue S; Kambe M; Sugiura K; Furukawa K; Furukawa K
    Biochem Biophys Res Commun; 2014 Mar; 445(2):504-10. PubMed ID: 24548412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
    Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
    Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects on proliferation and melanogenesis by inhibition of mutant BRAF and expression of wild-type INK4A in melanoma cells.
    Rotolo S; Diotti R; Gordon RE; Qiao RF; Yao Z; Phelps RG; Dong J
    Int J Cancer; 2005 May; 115(1):164-9. PubMed ID: 15657897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
    Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.
    Zeng H; Jorapur A; Shain AH; Lang UE; Torres R; Zhang Y; McNeal AS; Botton T; Lin J; Donne M; Bastian IN; Yu R; North JP; Pincus L; Ruben BS; Joseph NM; Yeh I; Bastian BC; Judson RL
    Cancer Cell; 2018 Jul; 34(1):56-68.e9. PubMed ID: 29990501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation.
    Al-Khalaf HH; Hendrayani SF; Aboussekhra A
    Mol Cancer Res; 2011 Mar; 9(3):311-9. PubMed ID: 21270107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contribution of p16(INK4a) to replicative senescence of human fibroblasts.
    Brookes S; Rowe J; Gutierrez Del Arroyo A; Bond J; Peters G
    Exp Cell Res; 2004 Aug; 298(2):549-59. PubMed ID: 15265701
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of p16(INK4A) and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: relationship with tumor growth parameters and ploidy status.
    Mariatos G; Gorgoulis VG; Zacharatos P; Kotsinas A; Vogiatzi T; Rassidakis G; Foukas P; Liloglou T; Tiniakos D; Angelou N; Manolis EN; Veslemes M; Field JK; Kittas C
    Int J Cancer; 2000 Mar; 89(2):133-41. PubMed ID: 10754490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.
    van Schanke A; van Venrooij GM; Jongsma MJ; Banus HA; Mullenders LH; van Kranen HJ; de Gruijl FR
    Cancer Res; 2006 Mar; 66(5):2608-15. PubMed ID: 16510579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Ultraviolet A-induced DNA damage: role in skin cancer].
    Beani JC
    Bull Acad Natl Med; 2014 Feb; 198(2):273-95. PubMed ID: 26263704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation.
    Scaini MC; Rossi E; de Siqueira Torres PL; Zullato D; Callegaro M; Casella C; Quaggio M; Agata S; Malacrida S; Chiarion-Sileni V; Vecchiato A; Alaibac M; Montagna M; Mann GJ; Menin C; D'Andrea E
    Mutat Res; 2009 Dec; 671(1-2):26-32. PubMed ID: 19712690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro behavior and UV response of melanocytes derived from carriers of CDKN2A mutations and MC1R variants.
    Hernando B; Swope VB; Guard S; Starner RJ; Choi K; Anwar A; Cassidy P; Leachman S; Kadekaro AL; Bennett DC; Abdel-Malek ZA
    Pigment Cell Melanoma Res; 2019 Mar; 32(2):259-268. PubMed ID: 30117292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.